Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Multiple Choice

Nausea and vomiting treatment may include which of the following pharmacologic and nonpharmacologic strategies?

Nausea and vomiting in palliative care are best managed with a multimodal approach that combines several antiemetic options from different pharmacologic classes with nonpharmacologic strategies. This reflects that N/V often has multiple causes and influences—opioid effects, gastric stasis, sensory and anxiety factors—so using multiple mechanisms can improve control and patient comfort. The pharmacologic part spans several pathways: anticholinergics can help with vestibular-related nausea; antihistamines address motion-related and sedating support; corticosteroids like dexamethasone provide antiemetic effects and help reduce inflammation that can contribute to nausea; prokinetics such as metoclopramide improve gastric emptying and reduce reflux-related symptoms; benzodiazepines help with anticipatory nausea and anxiety; 5-HT3 receptor antagonists (e.g., ondansetron) target serotonin-mediated nausea. Pairing these with nonpharmacologic approaches enhances relief: distraction or relaxation techniques reduce distress, while acupuncture, music, and hypnosis offer soothing, supportive benefits. Practical dietary adjustments—serving meals at room temperature with clear fluids, eating slowly, and avoiding large, bulky meals—can also lessen gastric load and improve tolerance. In contrast, focusing only on hydration and rest is helpful but incomplete, and relying on a single class of antiemetics ignores the multifactorial nature of N/V. Surgical interventions are not typical first-line management for nausea and vomiting in this setting.

Nausea and vomiting in palliative care are best managed with a multimodal approach that combines several antiemetic options from different pharmacologic classes with nonpharmacologic strategies. This reflects that N/V often has multiple causes and influences—opioid effects, gastric stasis, sensory and anxiety factors—so using multiple mechanisms can improve control and patient comfort.

The pharmacologic part spans several pathways: anticholinergics can help with vestibular-related nausea; antihistamines address motion-related and sedating support; corticosteroids like dexamethasone provide antiemetic effects and help reduce inflammation that can contribute to nausea; prokinetics such as metoclopramide improve gastric emptying and reduce reflux-related symptoms; benzodiazepines help with anticipatory nausea and anxiety; 5-HT3 receptor antagonists (e.g., ondansetron) target serotonin-mediated nausea. Pairing these with nonpharmacologic approaches enhances relief: distraction or relaxation techniques reduce distress, while acupuncture, music, and hypnosis offer soothing, supportive benefits. Practical dietary adjustments—serving meals at room temperature with clear fluids, eating slowly, and avoiding large, bulky meals—can also lessen gastric load and improve tolerance.

In contrast, focusing only on hydration and rest is helpful but incomplete, and relying on a single class of antiemetics ignores the multifactorial nature of N/V. Surgical interventions are not typical first-line management for nausea and vomiting in this setting.